SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-020964
Filing Date
2021-05-27
Accepted
2021-05-27 20:26:55
Documents
2
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3345
2 EX-24 DOCUMENT attachment1.htm EX-24 4795
  Complete submission text file 0000899243-21-020964.txt   9731
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Califf Robert (Reporting) CIK: 0001574557 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40445 | Film No.: 21975340

Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations